GLP1 medications should be used under the care of a qualified healthcare provider, and retatrutide is investigational and not approved for general use
And I will say, man, this is something I really changed my mind on for a long period of time
The body can make it, but demand may rise during illness, injury, intense training or other metabolic stress
Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization
By identifying these specific metabolic roadblocks, healthcare providers can move away from generalized fatigue management and toward targeted, precision medicine interventions like Carnitine Synergy, directly addressing the underlying cellular failures that drive these debilitating conditions